Intimation of Earnings Conference Call for the quarter ended Q2 & H1 FY26
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed the stock exchange that it will host an earnings conference call on Tuesday, 11th November 2025 at 12:30 p.m. to discuss its results for the second quarter and first half of FY26. The call is being arranged along with Kirin Advisors and will feature Managing Director Mr. Fredun Medhora as the speaker. Dial-in numbers and a Diamond Pass registration link have been shared for interested participants. No financial numbers or results have been disclosed in this intimation — actual figures will be discussed during the call.
This is a routine procedural filing with no immediate impact on the stock. Investors should watch for the company's Q2 and H1 FY26 results, which will be shared during the call on 11th November and could influence short-term price action depending on the numbers and management commentary.